-+ 0.00%
-+ 0.00%
-+ 0.00%

Jones Trading Downgrades Lumos Pharma to Hold, Lowers Price Target to $4.25

Benzinga·10/23/2024 21:09:57
Listen to the news
Jones Trading analyst Lina Kaminski downgrades Lumos Pharma (NASDAQ:LUMO) from Buy to Hold and lowers the price target from $20 to $4.25.